Experimental new therapies, regulatory changes, sustainability imperatives – biomanufacturers are navigating a changing ...
Zacks.com on MSN1h
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal IncreasesShares of Catalent CTLT lost 0.9% on Oct. 23 with the rise in uncertainty related to its acquisition by Novo Holding ...
The American Petroleum Institute (API) today has published Addendum 1 to API RP 2001, 10th Ed., “Fire Protection in Refineries.” This addendum strengthens existing fire safety measures by introducing ...
The latest update on Thursday morning shows Cencora shares down by 0.0%, trading at $234.52. At this price, Collis's 21,509 ...
Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 7 undervalued ...
Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...
Independent pharmacists are worried about growing financial and operational pressures that put a strain on their businesses. Some are worried they may have to close their doors.
Dr. Ernest Mario, a leader in the pharmaceutical industry, passed away at his son’s home in Durham, NC, on October 20, 2024, ...
West Pharmaceutical Services raised its annual profit forecast on Thursday, after beating Wall Street estimates for quarterly ...
Sandoz, Eli Lilly, Bayer, and Genentech executives tell what strikes them about the 2024 presidential race — and how the ...
Q&A: Mark Cuban explains his beef with traditional PBMs — and why he thinks disruption is inevitable
Mark Cuban is a man on a mission — to disrupt the pharmaceutical industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback